LONDON: Glycotest, a company developing blood tests for liver cancer, has received a $1 million follow-on investment from Fosun Industrial Co., Limited, a Chinese conglomerate. The investment is part of a $10 million deal signed in 2019, which also grants Fosun access to Glycotest’s intellectual property in certain situations. Fosun still owes $2 million to…
All posts tagged Glycotest
Glycotest receives $3mn second tranche of $10mn Series A financing
NEW YORK: Glycotest, Inc., a diagnostics company commercializing new and unique blood tests for life threatening liver cancers and fibrosis-cirrhosis, has received the second $3 million tranche of the $10 million Series A financing round from Shanghai Fosun Pharmaceutical Co., Ltd. The focus of this strategic investment is the advancement of the HCC Panel toward…